Summary and Info
Leading clinicians and researchers critically survey a decade of clinical, biological, and pathological knowledge, and show how it is best applied to the management of both localized and advanced renal cell carcinoma. Their discussions include the latest developments in molecular genetics and immune dysfunction, and fully treat the roles of partial nephrectomy, radical nephrectomy, and laparoscopy. Also discussed are screening for renal cell carcinoma, diagnosis and staging, paraneoplastic syndromes, and prognostic factors in metastatic disease. The physicians further explore novel therapeutic aspects including the use of interferon, Interleukin-2, therapy for metastatic renal cell carcinoma, monoclonal antibody therapies, and antiangiogenic treatments to name a few. Summarizing a decade of scientific and therapeutic innovation, Renal Cell Carcinoma offers all physicians and clinical investigators treating kidney cancer today's gold-standard compendium of practical knowledge about the nature, diagnosis, and treatment of this difficult disease.
More About the Author
Ronald M. Shapiro (born March 29, 1943 in Philadelphia, Pennsylvania) is an American attorney, sports agent, New York Times best selling author, negotiator, educator, speaker, and civic leader.
Review and Comments
Rate the Book
Renal Cell Carcinoma: Molecular Biology, Immunology, and Clinical Management (Current clinical Oncology) 0 out of 5 stars based on 0 ratings.